MOUNTAIN VIEW, Calif.,
Oct. 5, 2017 /PRNewswire/
-- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of
medication and supply management automation, analytics software,
and medication adherence solutions for healthcare organizations,
today announced it has been named as the Frost & Sullivan 2017
Global Smart Hospitals' Pharmacy Automation Vendor Company of the
Year. Following a global independent, comprehensive evaluation of
the vendor landscape, Frost & Sullivan analysts recognized
Omnicell's medication management portfolio, service offerings,
customer satisfaction, and financial performance. The Company of
the Year Award, part of Frost & Sullivan's Best Practices
Awards, is presented to the organization that demonstrates
excellence in growth, innovation, and leadership, with superior
performance in demand generation, brand development, and
competitive positioning.
"During our global review process for considering vendors for
our Best Practices Awards, we strive to identify the company that
is addressing existing challenges through future-ready technologies
that will adapt and grow with the market," said Siddharth Shah, Frost & Sullivan Industry
Analyst. "Omnicell's comprehensive approach to medication
management and customer loyalty and satisfaction were driving
factors in our team's decision. The combination of secure hardware
with cloud-based software that arms hospital teams with
decision-ready insights made Omnicell the clear leader in this
category."
Reimbursement trends, value-based care, and patient satisfaction
expectations pose challenges to today's hospitals. Healthcare
institutions must balance reducing costs, improving quality of care
and patient outcomes, and increasing overall efficiency. Frost
& Sullivan's analysis recognizes Omnicell's success in helping
customers use technology to navigate these challenges, citing its
comprehensive product portfolio that spans the entire continuum of
care and aligns with healthcare's shift into the community. With
hospital pharmacies and nursing, technology can make a dramatic
impact on increasing efficiency, enabling clinicians to spend more
time on patient care.
Omnicell approaches existing healthcare challenges with the goal
of providing automation that requires minimal manual input. For
example, Omnicell's robotic system for IV compounding is less
costly than outsourcing and provides hospital pharmacies with a
fully automated process that delivers greater accuracy. Advanced
interoperability between the Company's medication dispensing system
and leading electronic health record vendors reduces redundant
tasks for front-line staff, thereby increasing employee
satisfaction and patient safety. Technological solutions such as
these, along with Omnicell's commitment to customer experience and
satisfaction, contributed to Frost & Sullivan's decision.
"We're honored to be recognized for our product innovation and
commitment to our hospital, pharmacy, and non-acute care customers
in the U.S. and internationally," said Randall A. Lipps, chairman, president, CEO and
founder of Omnicell. "Our goal has always been to enable providers
to deliver better and more efficient care to patients—a balance
that is becoming increasingly challenging for our hospital
partners. We're committed to developing products and services that
ultimately help achieve this goal, and we continue to be inspired
by our customer partners as we work with them to find the best
solution to fit their needs."
For the Company of the Year Award, Frost & Sullivan analysts
independently evaluated two key factors: visionary innovation and
performance and customer impact. For more information on this
evaluation process, please view the complete Frost & Sullivan
report here.
The 2017 Smart Hospitals' Pharmacy Automation Vendor Company of
the Year Award will be presented to Omnicell at the Excellence in
Best Practices Awards Gala on January 24,
2018 in Anaheim, CA.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables
clients to accelerate growth and achieve best-in-class positions in
growth, innovation, and leadership. The company's Growth
Partnership Service provides the CEO and the CEO's Growth Team with
disciplined research and best practice models to drive the
generation, evaluation, and implementation of powerful growth
strategies. Frost & Sullivan leverages more than 50 years of
experience in partnering with Global 1000 companies, emerging
businesses, and the investment community from 45 offices on six
continents. To join our Growth Partnership, please visit
http://www.frost.com.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to
create safer and more efficient ways to manage medications and
supplies across all care settings. As a leader in medication and
supply dispensing automation, central pharmacy automation, IV
robotics, analytics software, and medication adherence and
packaging systems, Omnicell is focused on improving care across the
entire healthcare continuum—from the acute care hospital setting,
to post-acute skilled nursing and long-term care facilities, to the
patient's home.
Over 4,000 customers worldwide use
Omnicell® automation and analytics solutions to
increase operational efficiency, reduce medication errors, deliver
actionable intelligence and improve patient safety.
Omnicell's innovative medication adherence solutions, used by
over 32,000 institutional and retail pharmacies in North
America and the United Kingdom, are designed to improve
patient adherence to prescriptions, helping to reduce costly
hospital readmissions.
Recent Omnicell acquisitions, including Ateb, add distinct
capabilities, particularly in central pharmacy, IV robotics, and
pharmacy software, creating the broadest medication management
product portfolio in the industry.
For more information about Omnicell, Inc. please
visit www.omnicell.com.
OMCL-G
Editor's Notes:
- All Omnicell news releases (financial, acquisitions, products,
technology etc.) are issued exclusively by PR Newswire and are
immediately thereafter posted on the company's external
website, www.omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks
of Omnicell, Inc.
- All other brand or product names may be trademarks or
registered trademarks of their respective companies.
View original content with
multimedia:http://www.prnewswire.com/news-releases/frost--sullivan-names-omnicell-as-global-smart-hospitals-pharmacy-automation-vendor-company-of-the-year-300531632.html
SOURCE Omnicell, Inc.